[1]
Dr. Bikash Nayak et al. 2025. SAFETY AND EFFICACY OF TENOFOVIR DISOPROXIL FUMARATE VERSUS TENOFOVIR ALAFENAMIDE IN THE TREATMENT OF CHRONIC HEPATITIS B: A HOSPITAL-BASED OBSERVATIONAL STUDY. Journal of Population Therapeutics and Clinical Pharmacology. 32, 10 (Nov. 2025), 1152–1160. DOI:https://doi.org/10.53555/q6896466.